JNJ - Stifel Morgan Stanley bullish on newly public Contineum
2024-04-30 13:10:58 ET
More on Contineum Therapeutics, Inc.
- Contineum Therapeutics Seeks $150 Million IPO For MS Treatments
- Contineum Therapeutics stock slides 10% following $110M IPO
- Contineum Therapeutics prices initial offering at $16 per share
- Financial information for Contineum Therapeutics, Inc.